21 research outputs found

    San Pedro Mártir observations of microvariability in obscured quasars

    Get PDF
    Fast brightness variations are a unique tool to probe the innermost regions of active galactic nuclei (AGN). These variations are called microvariability or intra-night variability, and this phenomenon has been monitored in samples of blazars and unobscured AGNs. Detecting optical microvariations in targets hidden by the obscuring torus is a challenging task because the region responsible for the variations is hidden from our sight. However, there have been reports of fast variations in obscured Seyfert galaxies in X-rays, which rises the question whether microvariations can also be detected in obscured AGNs in the optical regime. Because the expected variations are very small and can easily be lost within the noise, the analysis requires a statistical approach. We report the use of a one-way analysis of variance, ANOVA, with which we searched for microvariability. ANOVA was successfully employed in previous studies of unobscured AGNs. As a result, we found microvariable events during three observing blocks: in two we observed the same object (Mrk 477), and in another, J0759+5050. The results on Mrk 477 confirm previous findings. However, since Mrk 477 is quite a peculiar target with hidden broad-line regions, we cannot rule out the possibility that we have serendipitously chosen a target prone to variations.This research has been supported by the Spanish Ministerio de Economía y Competitividad (MINECO) under the grant AYA2014-58861-C3-1. I.O. acknowledges support from the European Research Council (ERC) in the form of Advanced Grant, COSMICISM. J.A.D. is grateful for the support from the grant UNAM-DGAPA-PAPIIT IN110013 Program and the Canary islands CIE: Tricontinental Atlantic Campus. A.E. acknowledges support by the grant AYA2012-30789. J. I. González-Serrano is grateful for the support from AYA2011-29517-C03-02.Peer Reviewe

    The OTELO survey. A case study of [O III]4959,5007 emitters at <z> = 0.83

    Full text link
    The OTELO survey is a very deep, blind exploration of a selected region of the Extended Groth Strip and is designed for finding emission-line sources (ELSs). The survey design, observations, data reduction, astrometry, and photometry, as well as the correlation with ancillary data used to obtain a final catalogue, including photo-z estimates and a preliminary selection of ELS, were described in a previous contribution. Here, we aim to determine the main properties and luminosity function (LF) of the [O III] ELS sample of OTELO as a scientific demonstration of its capabilities, advantages, and complementarity with respect to other surveys. The selection and analysis procedures of ELS candidates obtained using tunable filter (TF) pseudo-spectra are described. We performed simulations in the parameter space of the survey to obtain emission-line detection probabilities. Relevant characteristics of [O III] emitters and the LF([O III]), including the main selection biases and uncertainties, are presented. A total of 184 sources were confirmed as [O III] emitters at a mean redshift z=0.83. The minimum detectable line flux and equivalent width (EW) in this ELS sample are \sim5 ×\times 1019^{-19} erg s1^{-1} cm2^{2} and \sim6 \AA, respectively. We are able to constrain the faint-end slope (α=1.03±0.08\alpha = -1.03\pm0.08) of the observed LF([O III]) at z=0.83. This LF reaches values that are approximately ten times lower than those from other surveys. The vast majority (84\%) of the morphologically classified [O III] ELSs are disc-like sources, and 87\% of this sample is comprised of galaxies with stellar masses of M_\star << 1010^{10} M_{\odot}.Comment: v1: 16 pages, 6 figures. Accepted in Astronomy \& Astrophysics. v2: Author added in metadat

    The OTELO survey III. Demography, morphology, IR luminosity and environment of AGN hosts

    Get PDF
    ABSTRACT: Aims. We take advantage of the capabilities of the OSIRIS Tunable Emission Line Object (OTELO) survey to select and study the AGN population in the field. In particular, we aim to perform an analysis of the properties of these objects, including their demography, morphology, and IR luminosity. Focusing on the population of Hα emitters at z∼0.4, we also aim to study the environments of AGN and non-AGN galaxies at that redshift. methods. We make use of the multiwavelength catalogue of objects in the field compiled by the OTELO survey, unique in terms of minimum flux and equivalent width. We also take advantage of the pseudo-spectra built for each source, which allow the identification of emission lines and the discrimination of different types of objects. Results. We obtained a sample of 72 AGNs in the field of OTELO, selected with four different methods in the optical, X-rays, and mid-infrared bands. We find that using X-rays is the most efficient way to select AGNs. An analysis was performed on the AGN population of OTELO in order to characterise its members. At z∼0.4, we find that up to 26% of our Hα emitters are AGNs. At that redshift, AGNs are found in identical environments to non-AGNs, although they represent the most clustered group when compared to passive and star-forming galaxies. The majority of our AGNs at any redshift were classified as late-type galaxies, including a 16% proportion of irregulars. Another 16% of AGNs show signs of interactions or mergers. Regarding the infrared luminosity, we are able to recover all the luminous infrared galaxies (LIRGs) in the field of OTELO up to z∼1.6. We find that the proportion of LIRGs and ultra-luminous infraed galaxies (ULIRGs) is higher among the AGN population, and that ULIRGs show a higher fraction of AGNs than LIRGs.This work was supported by the Spanish Ministry of Economy and Competitiveness (MINECO) under the grants AYA2013-46724 P, AYA2013-42227-P, AYA2014-58861-C3-1-P, AYA2014-58861-C3-2-P, AYA2014-58861-C3-3-P, AYA2016-75808-R, AYA2016-75931-C2-1-P, AYA2016-75931-C2-2-P, AYA2016-76682C3-1-P, AYA2017-88007-C3-1-P and AYA2017-88007-C3-2-P

    II. The faint-end of the Hα luminosity function at z ∼ 0.40

    Get PDF
    [Aims] We take advantage of the capability of the OTELO survey to obtain the H alpha luminosity function (LF) at z similar to 0.40. Because of the deepest coverage of OTELO, we are able to determine the faint end of the LF, and thus better constrain the star formation rate and the number of galaxies at low luminosities. The AGN contribution to this LF is estimated as well. [Methods] We make use of the multiwavelength catalogue of objects in the field compiled by the OTELO survey, which is unique in terms of minimum flux and equivalent width. We also take advantage of the pseudo-spectra built for each source, which allow the identification of emission lines and the discrimination of different types of objects. [Results] The H alpha luminosity function at z similar to 0.40 is obtained, which extends the current faint end by almost 1 dex, reaching minimal luminosities of log(10) L-lim = 38.5 erg s(-1) (or similar to 0.002 M-circle dot yr(-1)). The AGN contribution to the total H alpha luminosity is estimated. We find that no AGN should be expected below a luminosity of log(10) L = 38.6 erg s(-1). From the sample of non-AGN (presumably, pure SFG) at z similar to 0.40 we estimated a star formation rate density of rho(SFR) = 0.012 +/- 0.005 M-circle dot yr(-1) Mpc(-3).This work was supported by the Spanish Ministry of Economy and Competitiveness (MINECO) under the grants AYA2013- 46724- P, AYA2014 58861-C3-1- P, AYA2014-58861-C3-2-P, AYA2014-58861-C3-3- P, AYA2016 -75808-R, AYA2016-75931-C2-2-P, AYA2017-88007-C3-1-P, and AYA2017 -88007-C3-2- P. Based on observations made with the Gran Telescopio Canarias installed in the Spanish Observatorio del Roque de los Muchachos of the Instituto de Astrofisica de Canarias, in the island of La Palma. The authors thanks the anonymous referee for her/his feedback and suggestions

    The OTELO survey II. The faint-end of the Hα luminosity function at z ∼ 0.40

    Get PDF
    ABSTRACT: Aims. We take advantage of the capability of the OTELO survey to obtain the Hα luminosity function (LF) at z∼0.40. Because of the deepest coverage of OTELO, we are able to determine the faint end of the LF, and thus better constrain the star formation rate and the number of galaxies at low luminosities. The AGN contribution to this LF is estimated as well. Methods. We make use of the multiwavelength catalogue of objects in the field compiled by the OTELO survey, which is unique in terms of minimum flux and equivalent width. We also take advantage of the pseudo-spectra built for each source, which allow the identification of emission lines and the discrimination of different types of objects. Results. The Hα luminosity function at z∼0.40 is obtained, which extends the current faint end by almost 1 dex, reaching minimal luminosities of log10 Llim=38.5 erg s−1 (or ∼0.002 M yr−1). The AGN contribution to the total Hα luminosity is estimated. We find that no AGN should be expected below a luminosity of log10 L=38.6 erg s−1. From the sample of non-AGN (presumably, pure SFG) at z∼0.40 we estimated a star formation rate density of ρSFR = 0.012 ± 0.005 M yr−1 Mpc−3This work was supported by the Spanish Ministry of Economy and Competitiveness (MINECO) under the grants AYA2013-46724-P, AYA2014-58861-C3-1-P, AYA2014-58861-C3-2-P, AYA2014-58861-C3-3-P, AYA2016-75808-R, AYA2016-75931-C2-2-P, AYA2017-88007-C3-1-P, and AYA2017-88007-C3-2-

    The OTELO survey I. Description, data reduction, and multi-wavelength catalogue

    Get PDF
    ABSTRACT: Context. The evolution of galaxies through cosmic time is studied observationally by means of extragalactic surveys. The usefulness of these surveys is greatly improved by increasing the cosmological volume, in either depth or area, and by observing the same targets in different wavelength ranges. A multi-wavelength approach using different observational techniques can compensate for observational biases. Aims. The OTELO survey aims to provide the deepest narrow-band survey to date in terms of minimum detectable flux and emission line equivalent width in order to detect the faintest extragalactic emission line systems. In this way, OTELO data will c omplements other broad-band, narrow-band, and spectroscopic surveys. Methods. The red tunable filter of the OSIRIS instrument on the 10.4 m Gran Telescopio Canarias (GTC) is used to scan a spectral window centred at 9175 Å, which is free from strong sky emission lines, with a sampling interval of 6 Å and a bandwidth of 12 Å in the most deeply explored EGS region. Careful data reduction using improved techniques for sky ring subtraction, accurate astrometry, photometric calibration, and source extraction enables us to compile the OTELO catalogue. This catalogue is complemented with ancillary data ranging from deep X-ray to far-infrared, including high resolution HST images, which allow us to segregate the different types of targets, derive precise photometric redshifts, and obtain the morphological classification of the extragalactic objects detected. Results. The OTELO multi-wavelength catalogue contains 11 237 entries and is 50% complete at AB magnitude 26.38. Of these sources, 6600 have photometric redshifts with an uncertainty δ z phot better than 0.2 (1+z phot). A total of 4336 of these sources correspond to preliminary emission line candidates, which are complemented by 81 candidate stars and 483 sources that qualify as absorption line systems. The OTELO survey results will be released to the public on the second half of 2019.This work was supported by the Spanish Ministry of Economy and Competitiveness (MINECO) under the grants AYA2013-46724-P, AYA2014-58861-C3-1-P, AYA2014-58861-C3-2-P, AYA2014-58861-C3-3-P, AYA2016-75808-R, AYA2016-75931-C2-2-P, AYA2017-88007-C3-1-P and AYA2017-88007-C3-2-P

    Role of age and comorbidities in mortality of patients with infective endocarditis

    Get PDF
    [Purpose]: The aim of this study was to analyse the characteristics of patients with IE in three groups of age and to assess the ability of age and the Charlson Comorbidity Index (CCI) to predict mortality. [Methods]: Prospective cohort study of all patients with IE included in the GAMES Spanish database between 2008 and 2015.Patients were stratified into three age groups:<65 years,65 to 80 years,and ≥ 80 years.The area under the receiver-operating characteristic (AUROC) curve was calculated to quantify the diagnostic accuracy of the CCI to predict mortality risk. [Results]: A total of 3120 patients with IE (1327 < 65 years;1291 65-80 years;502 ≥ 80 years) were enrolled.Fever and heart failure were the most common presentations of IE, with no differences among age groups.Patients ≥80 years who underwent surgery were significantly lower compared with other age groups (14.3%,65 years; 20.5%,65-79 years; 31.3%,≥80 years). In-hospital mortality was lower in the <65-year group (20.3%,<65 years;30.1%,65-79 years;34.7%,≥80 years;p < 0.001) as well as 1-year mortality (3.2%, <65 years; 5.5%, 65-80 years;7.6%,≥80 years; p = 0.003).Independent predictors of mortality were age ≥ 80 years (hazard ratio [HR]:2.78;95% confidence interval [CI]:2.32–3.34), CCI ≥ 3 (HR:1.62; 95% CI:1.39–1.88),and non-performed surgery (HR:1.64;95% CI:11.16–1.58).When the three age groups were compared,the AUROC curve for CCI was significantly larger for patients aged <65 years(p < 0.001) for both in-hospital and 1-year mortality. [Conclusion]: There were no differences in the clinical presentation of IE between the groups. Age ≥ 80 years, high comorbidity (measured by CCI),and non-performance of surgery were independent predictors of mortality in patients with IE.CCI could help to identify those patients with IE and surgical indication who present a lower risk of in-hospital and 1-year mortality after surgery, especially in the <65-year group

    Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19)

    Get PDF
    Objectives: The objective of this study was to estimate the association between tocilizumab or corticosteroids and the risk of intubation or death in patients with coronavirus disease 19 (COVID-19) with a hyperinflammatory state according to clinical and laboratory parameters. Methods: A cohort study was performed in 60 Spanish hospitals including 778 patients with COVID-19 and clinical and laboratory data indicative of a hyperinflammatory state. Treatment was mainly with tocilizumab, an intermediate-high dose of corticosteroids (IHDC), a pulse dose of corticosteroids (PDC), combination therapy, or no treatment. Primary outcome was intubation or death; follow-up was 21 days. Propensity score-adjusted estimations using Cox regression (logistic regression if needed) were calculated. Propensity scores were used as confounders, matching variables and for the inverse probability of treatment weights (IPTWs). Results: In all, 88, 117, 78 and 151 patients treated with tocilizumab, IHDC, PDC, and combination therapy, respectively, were compared with 344 untreated patients. The primary endpoint occurred in 10 (11.4%), 27 (23.1%), 12 (15.4%), 40 (25.6%) and 69 (21.1%), respectively. The IPTW-based hazard ratios (odds ratio for combination therapy) for the primary endpoint were 0.32 (95%CI 0.22-0.47; p < 0.001) for tocilizumab, 0.82 (0.71-1.30; p 0.82) for IHDC, 0.61 (0.43-0.86; p 0.006) for PDC, and 1.17 (0.86-1.58; p 0.30) for combination therapy. Other applications of the propensity score provided similar results, but were not significant for PDC. Tocilizumab was also associated with lower hazard of death alone in IPTW analysis (0.07; 0.02-0.17; p < 0.001). Conclusions: Tocilizumab might be useful in COVID-19 patients with a hyperinflammatory state and should be prioritized for randomized trials in this situatio

    Spatiotemporal Characteristics of the Largest HIV-1 CRF02_AG Outbreak in Spain: Evidence for Onward Transmissions

    Get PDF
    Background and Aim: The circulating recombinant form 02_AG (CRF02_AG) is the predominant clade among the human immunodeficiency virus type-1 (HIV-1) non-Bs with a prevalence of 5.97% (95% Confidence Interval-CI: 5.41–6.57%) across Spain. Our aim was to estimate the levels of regional clustering for CRF02_AG and the spatiotemporal characteristics of the largest CRF02_AG subepidemic in Spain.Methods: We studied 396 CRF02_AG sequences obtained from HIV-1 diagnosed patients during 2000–2014 from 10 autonomous communities of Spain. Phylogenetic analysis was performed on the 391 CRF02_AG sequences along with all globally sampled CRF02_AG sequences (N = 3,302) as references. Phylodynamic and phylogeographic analysis was performed to the largest CRF02_AG monophyletic cluster by a Bayesian method in BEAST v1.8.0 and by reconstructing ancestral states using the criterion of parsimony in Mesquite v3.4, respectively.Results: The HIV-1 CRF02_AG prevalence differed across Spanish autonomous communities we sampled from (p &lt; 0.001). Phylogenetic analysis revealed that 52.7% of the CRF02_AG sequences formed 56 monophyletic clusters, with a range of 2–79 sequences. The CRF02_AG regional dispersal differed across Spain (p = 0.003), as suggested by monophyletic clustering. For the largest monophyletic cluster (subepidemic) (N = 79), 49.4% of the clustered sequences originated from Madrid, while most sequences (51.9%) had been obtained from men having sex with men (MSM). Molecular clock analysis suggested that the origin (tMRCA) of the CRF02_AG subepidemic was in 2002 (median estimate; 95% Highest Posterior Density-HPD interval: 1999–2004). Additionally, we found significant clustering within the CRF02_AG subepidemic according to the ethnic origin.Conclusion: CRF02_AG has been introduced as a result of multiple introductions in Spain, following regional dispersal in several cases. We showed that CRF02_AG transmissions were mostly due to regional dispersal in Spain. The hot-spot for the largest CRF02_AG regional subepidemic in Spain was in Madrid associated with MSM transmission risk group. The existence of subepidemics suggest that several spillovers occurred from Madrid to other areas. CRF02_AG sequences from Hispanics were clustered in a separate subclade suggesting no linkage between the local and Hispanic subepidemics

    The IDENTIFY study: the investigation and detection of urological neoplasia in patients referred with suspected urinary tract cancer - a multicentre observational study

    Get PDF
    Objective To evaluate the contemporary prevalence of urinary tract cancer (bladder cancer, upper tract urothelial cancer [UTUC] and renal cancer) in patients referred to secondary care with haematuria, adjusted for established patient risk markers and geographical variation. Patients and Methods This was an international multicentre prospective observational study. We included patients aged ≥16 years, referred to secondary care with suspected urinary tract cancer. Patients with a known or previous urological malignancy were excluded. We estimated the prevalence of bladder cancer, UTUC, renal cancer and prostate cancer; stratified by age, type of haematuria, sex, and smoking. We used a multivariable mixed-effects logistic regression to adjust cancer prevalence for age, type of haematuria, sex, smoking, hospitals, and countries. Results Of the 11 059 patients assessed for eligibility, 10 896 were included from 110 hospitals across 26 countries. The overall adjusted cancer prevalence (n = 2257) was 28.2% (95% confidence interval [CI] 22.3–34.1), bladder cancer (n = 1951) 24.7% (95% CI 19.1–30.2), UTUC (n = 128) 1.14% (95% CI 0.77–1.52), renal cancer (n = 107) 1.05% (95% CI 0.80–1.29), and prostate cancer (n = 124) 1.75% (95% CI 1.32–2.18). The odds ratios for patient risk markers in the model for all cancers were: age 1.04 (95% CI 1.03–1.05; P < 0.001), visible haematuria 3.47 (95% CI 2.90–4.15; P < 0.001), male sex 1.30 (95% CI 1.14–1.50; P < 0.001), and smoking 2.70 (95% CI 2.30–3.18; P < 0.001). Conclusions A better understanding of cancer prevalence across an international population is required to inform clinical guidelines. We are the first to report urinary tract cancer prevalence across an international population in patients referred to secondary care, adjusted for patient risk markers and geographical variation. Bladder cancer was the most prevalent disease. Visible haematuria was the strongest predictor for urinary tract cancer
    corecore